HealthDay on MSN23h
Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol Consumption
(HealthDay News) — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals, according to a study published online Nov. 14 in ...
Even with access to blockbuster obesity drugs, some people don't lose weight
In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...
Inquirer on MSN4h
Even with access to new obesity drugs, some people don’t lose weight
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology ...